To ask the Secretary of State for Health and Social Care, if he will take steps to financially support local health systems to achieve greater uptake of rapid point-of-care diagnostics ahead of the forthcoming winter season.
4 July 2022
Throughout the pandemic, the UK Health Security Agency (UKHSA) has made COVID-19 polymerase chain reaction (PCR) and lateral flow device (LFD) tests available for primary care, as clinically required. The UKHSA continues to provide LFD and PCR testing for individuals in high-risk settings, including in primary and community care.
Multiplex testing is available to primary and community care services through National Health Service laboratories, which accelerates access to diagnostics and enables effective management of respiratory infections. While the UKHSA keeps the deployment of multiplex testing in primary care settings under review, there are no current plans for its provision in primary care settings.